Sycamore Labs | $65,000,000 | (Mar 31, 2026)
Deccan AI | $25,000,000 | (Mar 31, 2026)
Stedi | $50,000,000 | (Mar 31, 2026)
Asterix Foods
Israel
- Tel Aviv
- 10/10/2025
- Seed
- $4,200,000
Industry leading companies like Impossible, Perfect Day (RebelBio), and EVERY (IndieBio) have shown the powerful commercial appeal of animal-free proteins. Behind this first wave comes a second wave: glycoproteins.
Glycoproteins require precise glycosylations to accurately fold, recognize, and bind – driving functional performance needed in the food industry. To unlock this second wave of animal-free proteins, Asterix Foods is using plant cells, because plant cells can easily achieve glycosylations that microbial fermentation is challenged by.
- Industry Biotechnology
- Website https://www.asterixfoods.com/
- LinkedIn https://www.linkedin.com/company/asterix-foods/
Related People
Dan EvenFounder
Israel -
Tel Aviv District
Experienced in Molecular Biology, Plant Genetic Engineering, and Plant Biology.
Specializing in: Research and Development, Biotechnology, Molecular Biology, Alternative Food & Protein, Plant Biology, Plant Genetic Engineering, Protein Purification & Expression, Antibody Engineering, Microbiology.
OpenBox AI | $5,000,000 | (Mar 31, 2026)
Qodo | $70,000,000 | (Mar 31, 2026)
Starcloud | $170,000,000 | (Mar 31, 2026)
Valinor(1) | $25,000,000 | (Mar 31, 2026)
Mars Men | $27,500,000 | (Mar 31, 2026)
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)